Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$124.76
At close: Jun 24 EDT
$125.00
0.240.19%
Pre-Market: 8:34 AM EDT
Comments
Loading...
Biogen Analyst Ratings and Price Targets | NASDAQ:BIIB | Benzinga
Biogen Inc has a consensus price target of $202.38 based on the ratings of 30 analysts. The high is $342 issued by HSBC on May 3, 2024. The low is $115 issued by Piper Sandler on June 12, 2025. The 3 most-recent analyst ratings were released by Piper Sandler, Wedbush, and Mizuho on June 12, 2025, June 12, 2025, and May 7, 2025, respectively. With an average price target of $135 between Piper Sandler, Wedbush, and Mizuho, there's an implied 8.00% upside for Biogen Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Piper Sandler
Wedbush
Mizuho
JP Morgan
RBC Capital
1calculated from analyst ratings
Analyst Ratings for Biogen
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/12/2025 | Buy Now | -8% | Piper Sandler | David Amsellem73% | $115 → $115 | Reiterates | Neutral → Neutral | Get Alert |
| 06/12/2025 | Buy Now | -3.2% | Wedbush | Laura Chico51% | $121 → $121 | Reiterates | Neutral → Neutral | Get Alert |
| 06/12/2025 | Buy Now | — | Needham | Ami Fadia59% | — | Reiterates | Hold → Hold | Get Alert |
| 05/07/2025 | Buy Now | 35.2% | Mizuho | Salim Syed44% | $207 → $169 | Maintains | Outperform | Get Alert |
| 05/05/2025 | Buy Now | 40% | JP Morgan | Chris Schott59% | $185 → $175 | Maintains | Neutral | Get Alert |
| 05/02/2025 | Buy Now | 64% | RBC Capital | Brian Abrahams49% | $217 → $205 | Maintains | Outperform | Get Alert |
| 05/02/2025 | Buy Now | 76% | Canaccord Genuity | Sumant Kulkarni43% | $265 → $220 | Maintains | Buy | Get Alert |
| 05/02/2025 | Buy Now | 49.6% | HC Wainwright & Co. | Andrew Fein60% | $241 → $187 | Maintains | Buy | Get Alert |
| 05/02/2025 | Buy Now | 104% | Baird | Brian Skorney58% | $300 → $255 | Maintains | Outperform | Get Alert |
| 05/02/2025 | Buy Now | — | Needham | Ami Fadia59% | — | Reiterates | Hold → Hold | Get Alert |
| 04/29/2025 | Buy Now | 59.2% | Truist Securities | Srikripa Devarakonda42% | $210 → $199 | Maintains | Buy | Get Alert |
| 04/29/2025 | Buy Now | -8% | Piper Sandler | Christopher Raymond55% | $135 → $115 | Maintains | Neutral | Get Alert |
| 04/25/2025 | Buy Now | — | Needham | Ami Fadia59% | — | Reiterates | Hold → Hold | Get Alert |
| 04/23/2025 | Buy Now | 57.6% | Goldman Sachs | Salveen Richter51% | $219 → $197 | Maintains | Buy | Get Alert |
| 04/22/2025 | Buy Now | 80% | RBC Capital | Brian Abrahams49% | $221 → $225 | Maintains | Outperform | Get Alert |
| 04/16/2025 | Buy Now | — | Needham | Ami Fadia59% | — | Reiterates | Hold → Hold | Get Alert |
| 04/09/2025 | Buy Now | 21.6% | Morgan Stanley | Matthew Harrison61% | $157 → $152 | Maintains | Equal-Weight | Get Alert |
| 04/04/2025 | Buy Now | — | Argus Research | Jasper Hellweg68% | — | Downgrade | Buy → Hold | Get Alert |
| 02/18/2025 | Buy Now | 8% | Piper Sandler | Christopher Raymond55% | $138 → $135 | Reiterates | Neutral → Neutral | Get Alert |
| 02/13/2025 | Buy Now | 79.2% | Scotiabank | George Farmer46% | $244 → $224 | Maintains | Sector Outperform | Get Alert |
| 02/13/2025 | Buy Now | 11.2% | BMO Capital | Evan Seigerman63% | $156 → $139 | Maintains | Market Perform | Get Alert |
| 02/13/2025 | Buy Now | 25.6% | Morgan Stanley | Matthew Harrison61% | $192 → $157 | Maintains | Equal-Weight | Get Alert |
| 02/13/2025 | Buy Now | 96% | Goldman Sachs | Salveen Richter51% | $281 → $245 | Maintains | Buy | Get Alert |
| 02/13/2025 | Buy Now | 80% | RBC Capital | Brian Abrahams49% | $231 → $225 | Maintains | Outperform | Get Alert |
| 02/13/2025 | Buy Now | 16% | Citigroup | Geoff Meacham62% | $160 → $145 | Maintains | Neutral | Get Alert |
| 02/13/2025 | Buy Now | 12% | Wells Fargo | Mohit Bansal67% | $165 → $140 | Maintains | Equal-Weight | Get Alert |
| 02/13/2025 | Buy Now | 92.8% | HC Wainwright & Co. | Andrew Fein60% | $300 → $241 | Maintains | Buy | Get Alert |
| 02/13/2025 | Buy Now | 68% | Truist Securities | Srikripa Devarakonda42% | $220 → $210 | Maintains | Buy | Get Alert |
| 02/13/2025 | Buy Now | 112% | Canaccord Genuity | Sumant Kulkarni43% | $298 → $265 | Maintains | Buy | Get Alert |
| 02/13/2025 | Buy Now | — | Needham | Ami Fadia59% | — | Reiterates | Hold → Hold | Get Alert |
| 01/28/2025 | Buy Now | 28% | Citigroup | Geoff Meacham62% | $190 → $160 | Maintains | Neutral | Get Alert |
| 01/10/2025 | Buy Now | 32% | Wells Fargo | Mohit Bansal67% | $190 → $165 | Maintains | Equal-Weight | Get Alert |
| 01/08/2025 | Buy Now | 76% | Truist Securities | Srikripa Devarakonda42% | $302 → $220 | Maintains | Buy | Get Alert |
| 01/02/2025 | Buy Now | 10.4% | Piper Sandler | Christopher Raymond55% | $315 → $138 | Downgrade | Overweight → Neutral | Get Alert |
| 12/20/2024 | Buy Now | 31.2% | BMO Capital | Evan Seigerman63% | $230 → $164 | Downgrade | Outperform → Market Perform | Get Alert |
| 12/10/2024 | Buy Now | 42.4% | B of A Securities | Tim Anderson63% | → $178 | Reinstates | → Neutral | Get Alert |
| 12/09/2024 | Buy Now | 44% | Jefferies | Michael Yee56% | $250 → $180 | Downgrade | Buy → Hold | Get Alert |
| 11/21/2024 | Buy Now | 65.6% | Mizuho | Salim Syed44% | $251 → $207 | Maintains | Outperform | Get Alert |
| 11/18/2024 | Buy Now | 116% | Needham | Ami Fadia59% | $270 → $270 | Downgrade | Buy → Hold | Get Alert |
| 11/15/2024 | Buy Now | 140% | Baird | Brian Skorney58% | $294 → $300 | Maintains | Outperform | Get Alert |
| 11/15/2024 | Buy Now | — | Wolfe Research | Alexandria Hammond46% | — | Initiates | → Peer Perform | Get Alert |
| 11/14/2024 | Buy Now | 52% | Citigroup | Geoff Meacham62% | → $190 | Initiates | → Neutral | Get Alert |
| 11/04/2024 | Buy Now | 68% | JP Morgan | Chris Schott59% | $220 → $210 | Maintains | Neutral | Get Alert |
| 10/31/2024 | Buy Now | 104% | Oppenheimer | Jay Olson60% | $270 → $255 | Maintains | Outperform | Get Alert |
| 10/31/2024 | Buy Now | 44% | Barclays | Carter Gould55% | $190 → $180 | Maintains | Equal-Weight | Get Alert |
| 10/31/2024 | Buy Now | 120% | TD Cowen | Phil Nadeau66% | $300 → $275 | Maintains | Buy | Get Alert |
| 10/31/2024 | Buy Now | 140% | HC Wainwright & Co. | Andrew Fein60% | $300 → $300 | Reiterates | Buy → Buy | Get Alert |
| 10/31/2024 | Buy Now | 116% | Needham | Ami Fadia59% | $270 → $270 | Reiterates | Buy → Buy | Get Alert |
| 10/31/2024 | Buy Now | 63.2% | Morgan Stanley | Matthew Harrison61% | $285 → $204 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 10/30/2024 | Buy Now | 116% | Needham | Ami Fadia59% | $270 → $270 | Reiterates | Buy → Buy | Get Alert |
| 10/17/2024 | Buy Now | 84% | BMO Capital | Evan Seigerman63% | $260 → $230 | Maintains | Outperform | Get Alert |
| 10/10/2024 | Buy Now | — | Raymond James | Danielle Brill42% | — | Reinstates | → Market Perform | Get Alert |
| 10/04/2024 | Buy Now | 115.2% | RBC Capital | Brian Abrahams49% | $292 → $269 | Maintains | Outperform | Get Alert |
| 10/03/2024 | Buy Now | 61.6% | UBS | Colin Bristow39% | $234 → $202 | Maintains | Neutral | Get Alert |
| 09/24/2024 | Buy Now | 128% | Needham | Ami Fadia59% | $285 → $285 | Reiterates | Buy → Buy | Get Alert |
| 09/23/2024 | Buy Now | 64% | Wedbush | Laura Chico51% | $210 → $205 | Maintains | Neutral | Get Alert |
| 09/19/2024 | Buy Now | 133.6% | RBC Capital | Brian Abrahams49% | $292 → $292 | Reiterates | Outperform → Outperform | Get Alert |
| 09/09/2024 | Buy Now | 133.6% | Cantor Fitzgerald | Eric Schmidt32% | $292 → $292 | Reiterates | Overweight → Overweight | Get Alert |
| 09/04/2024 | Buy Now | 128% | Needham | Ami Fadia59% | $285 → $285 | Reiterates | Buy → Buy | Get Alert |
| 08/19/2024 | Buy Now | 128% | Needham | Ami Fadia59% | $285 → $285 | Reiterates | Buy → Buy | Get Alert |
| 08/06/2024 | Buy Now | 100.8% | Mizuho | Salim Syed44% | $277 → $251 | Maintains | Outperform | Get Alert |
| 08/05/2024 | Buy Now | 141.6% | Truist Securities | Srikripa Devarakonda42% | $340 → $302 | Reiterates | Buy → Buy | Get Alert |
| 08/05/2024 | Buy Now | 128% | Needham | Ami Fadia59% | $288 → $285 | Maintains | Buy | Get Alert |
| 08/02/2024 | Buy Now | 133.6% | RBC Capital | Brian Abrahams49% | $282 → $292 | Maintains | Outperform | Get Alert |
| 08/02/2024 | Buy Now | 80% | Wells Fargo | Mohit Bansal67% | $240 → $225 | Maintains | Equal-Weight | Get Alert |
| 08/02/2024 | Buy Now | 95.2% | Scotiabank | George Farmer46% | $275 → $244 | Maintains | Sector Outperform | Get Alert |
| 08/02/2024 | Buy Now | 52% | Barclays | Carter Gould55% | $200 → $190 | Maintains | Equal-Weight | Get Alert |
| 08/02/2024 | Buy Now | 68% | Wedbush | Laura Chico51% | $215 → $210 | Maintains | Neutral | Get Alert |
| 08/01/2024 | Buy Now | 130.4% | Needham | Ami Fadia59% | $288 → $288 | Reiterates | Buy → Buy | Get Alert |
| 07/29/2024 | Buy Now | 135.2% | Baird | Brian Skorney58% | $316 → $294 | Maintains | Outperform | Get Alert |
| 07/26/2024 | Buy Now | 135.2% | Needham | Ami Fadia59% | $294 → $294 | Reiterates | Buy → Buy | Get Alert |
| 07/12/2024 | Buy Now | 150.4% | Piper Sandler | Christopher Raymond55% | $335 → $313 | Maintains | Overweight | Get Alert |
| 06/28/2024 | Buy Now | 135.2% | Needham | Ami Fadia59% | $294 → $294 | Reiterates | Buy → Buy | Get Alert |
| 06/27/2024 | Buy Now | 153.6% | RBC Capital | Brian Abrahams49% | $317 → $317 | Reiterates | Outperform → Outperform | Get Alert |
| 06/26/2024 | Buy Now | 153.6% | RBC Capital | Brian Abrahams49% | $317 → $317 | Reiterates | Outperform → Outperform | Get Alert |
| 06/05/2024 | Buy Now | 153.6% | RBC Capital | Brian Abrahams49% | $317 → $317 | Reiterates | Outperform → Outperform | Get Alert |
| 05/29/2024 | Buy Now | 153.6% | RBC Capital | Brian Abrahams49% | → $317 | Reiterates | Outperform → Outperform | Get Alert |
| 05/23/2024 | Buy Now | 140% | HC Wainwright & Co. | Andrew Fein60% | $300 → $300 | Reiterates | Buy → Buy | Get Alert |
| 05/22/2024 | Buy Now | 135.2% | Needham | Ami Fadia59% | $294 → $294 | Reiterates | Buy → Buy | Get Alert |
| 05/16/2024 | Buy Now | 172% | Truist Securities | Robyn Karnauskas54% | $340 → $340 | Maintains | Buy | Get Alert |
| 05/03/2024 | Buy Now | 173.6% | HSBC | Morten Herholdt36% | $339 → $342 | Maintains | Buy | Get Alert |
| 04/29/2024 | Buy Now | 116% | Oppenheimer | Jay Olson60% | $270 → $270 | Maintains | Outperform | Get Alert |
| 04/25/2024 | Buy Now | 135.2% | Needham | Ami Fadia59% | $294 → $294 | Reiterates | Buy → Buy | Get Alert |
| 04/25/2024 | Buy Now | 60% | Barclays | Carter Gould55% | $215 → $200 | Maintains | Equal-Weight | Get Alert |
| 04/25/2024 | Buy Now | 72% | Wedbush | Laura Chico51% | $213 → $215 | Maintains | Neutral | Get Alert |
| 04/25/2024 | Buy Now | 140% | HC Wainwright & Co. | Andrew Fein60% | $325 → $300 | Maintains | Buy | Get Alert |
| 04/24/2024 | Buy Now | 135.2% | Needham | Ami Fadia59% | $294 → $294 | Reiterates | Buy → Buy | Get Alert |
| 04/19/2024 | Buy Now | 116% | Oppenheimer | Jay Olson60% | $290 → $270 | Maintains | Outperform | Get Alert |
| 04/17/2024 | Buy Now | 71.2% | UBS | Colin Bristow39% | $250 → $214 | Maintains | Neutral | Get Alert |
| 04/17/2024 | Buy Now | 70.4% | Wedbush | Laura Chico51% | $245 → $213 | Maintains | Neutral | Get Alert |
| 04/12/2024 | Buy Now | 108% | B of A Securities | Geoff Meacham62% | $280 → $260 | Maintains | Neutral | Get Alert |
| 04/11/2024 | Buy Now | 92% | JP Morgan | Chris Schott59% | $270 → $240 | Maintains | Neutral | Get Alert |
| 04/04/2024 | Buy Now | 72% | Barclays | Carter Gould55% | $230 → $215 | Maintains | Equal-Weight | Get Alert |
| 03/25/2024 | Buy Now | 172% | Truist Securities | Robyn Karnauskas54% | → $340 | Reiterates | Buy → Buy | Get Alert |
| 03/05/2024 | Buy Now | 191.2% | RBC Capital | Brian Abrahams49% | $364 → $364 | Reiterates | Outperform → Outperform | Get Alert |
| 02/22/2024 | Buy Now | 121.6% | Mizuho | Salim Syed44% | $355 → $277 | Maintains | Buy | Get Alert |
| 02/20/2024 | Buy Now | 148.8% | Cantor Fitzgerald | Eric Schmidt32% | $311 → $311 | Reiterates | Overweight → Overweight | Get Alert |
| 02/20/2024 | Buy Now | 144% | Canaccord Genuity | Sumant Kulkarni43% | $310 → $305 | Maintains | Buy | Get Alert |
| 02/16/2024 | Buy Now | 100% | UBS | Colin Bristow39% | $276 → $250 | Maintains | Neutral | Get Alert |
| 02/14/2024 | Buy Now | 160% | HC Wainwright & Co. | Andrew Fein60% | $325 → $325 | Reiterates | Buy → Buy | Get Alert |
FAQ
What is the target price for Biogen (BIIB) stock?
The latest price target for Biogen (NASDAQ:BIIB) was reported by Piper Sandler on June 12, 2025. The analyst firm set a price target for $115.00 expecting BIIB to fall to within 12 months (a possible -8.00% downside). 75 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Biogen (BIIB)?
The latest analyst rating for Biogen (NASDAQ:BIIB) was provided by Piper Sandler, and Biogen reiterated their neutral rating.
When was the last upgrade for Biogen (BIIB)?
There is no last upgrade for Biogen
When was the last downgrade for Biogen (BIIB)?
The last downgrade for Biogen Inc happened on April 4, 2025 when Argus Research changed their price target from N/A to N/A for Biogen Inc.
When is the next analyst rating going to be posted or updated for Biogen (BIIB)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Biogen, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Biogen was filed on June 12, 2025 so you should expect the next rating to be made available sometime around June 12, 2026.
Is the Analyst Rating Biogen (BIIB) correct?
While ratings are subjective and will change, the latest Biogen (BIIB) rating was a reiterated with a price target of $115.00 to $115.00. The current price Biogen (BIIB) is trading at is $125.00, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
